Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 2/20 | 0.55 |
| ▸ | PNMT | P11086 | 3/20 | 0.60 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 7/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2522138 | 1.00 | PNMT (0.60) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Hydrochloric Acid SCHEMBL30297049 | 1.00 | PNMT (0.60) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Hydrochloric Acid SCHEMBL31276815 | 1.00 | PNMT (0.60) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Hydrochloric Acid SCHEMBL29080507 | 0.97 | PNMT (0.57) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| SCHEMBL29405036 | 0.96 | PNMT (0.63) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| SCHEMBL15247 | 0.96 | PNMT (0.63) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Benzene SCHEMBL734438 | 0.93 | DPP4 (0.62) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Water SCHEMBL6142580 | 0.93 | PNMT (0.60) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Iodide SCHEMBL28958724 | 0.93 | PNMT (0.60) | PNMTDPP4LOXL2TAAR1CYP2A6 | |
| Water SCHEMBL7618285 | 0.93 | PNMT (0.60) | PNMTDPP4LOXL2TAAR1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082611-A | Mutant of aminotransferase and application thereof | 上海合全药业股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| US-20240166795-A1 | XYLYLENE DIISOCYNATE COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2024-05-23 | — | — | US | claimed |
| EP-4306509-A1 | XYLYLENE DIISOCYNATE COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | Wanhua Chemical Group Co., Ltd (CN) | 2024-01-17 | — | — | EP | claimed |
| CN-115073707-B | Benzenedimethylene diisocyanate composition and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-115073707-A | Xylylene diisocyanate composition and preparation method and application thereof | 万华化学集团股份有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2022188825-A1 | XYLYLENE DIISOCYNATE COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | 万华化学集团股份有限公司 | 2022-09-15 | — | — | WO | claimed |
| CN-111132960-B | Process for preparing aliphatic isocyanates | 韩华思路信(株) | 2022-08-16 | — | — | CN | claimed |
| CN-114645027-A | Aminotransferase mutant from bacillus megatherium and application thereof | 上海合全药物研发有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-111217975-B | Method for producing resin for optical material | 万华化学集团股份有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-109153637-B | Xylylene diisocyanate composition, xylylene diisocyanate modified product composition, two-pack type resin raw material, and resin | 三井化学株式会社 | 2020-12-08 | — | — | CN | claimed |
| CN-111217975-A | Method for producing resin for optical material | 万华化学集团股份有限公司 | 2020-06-02 | — | — | CN | claimed |
| EP-0384463-B1 | Preparation process of xylylene diisocyanate | MITSUI TOATSU CHEMICALS (JP) | 1994-08-10 | — | — | EP | claimed |
| CN-121574342-A | Benzenedimethylene diisocyanate composition, preparation method and application thereof | 万华化学集团股份有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-120082611-A | Mutant of aminotransferase and application thereof | 上海合全药业股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025079550-A1 | XYLYLENE DIISOCYANATE COMPOSITION, POLYMERIZABLE COMPOSITION, RESIN, MOLDED BODY, OPTICAL ELEMENT, AND LENS | 三井化学株式会社 | 2025-04-17 | — | — | WO | disclosed |
| CN-119822999-A | Benzenedimethylene diisocyanate composition, preparation method and application thereof | 万华化学集团股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-0765313-B1 | N,N'-BIS(QUINOLIN-4-YL)-DIAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMALARIALS | HOFFMANN LA ROCHE (CH) | 2003-08-20 | — | — | EP | disclosed |
| US-5736557-A | MICROBIOCIDE EFFECTIVE AGAINST CHLOROQUINE-RESISTANT AND CHLOROQUINE-SENSITIVE STRAINS OF PLASMODIUM FALCIPARUM | HOFFMAN-LA ROCHE, INC. (US) | 1998-04-07 | — | — | US | disclosed |
| EP-0765313-A1 | N,N'-BIS(QUINOLIN-4-YL)-DIAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMALARIALS | F. HOFFMANN-LA ROCHE AG (CH) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995035287-A1 | N,N'-BIS(QUINOLIN-4-YL)-DIAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMALARIALS | F.HOFFMANN-LA ROCHE AG (CH) | 1995-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166795-A1 | XYLYLENE DIISOCYNATE COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | DCXR, NOTUM, FDFT1 | DPP4 1780/4885PNMT 3348/4885LOXL2 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.